Calidi Biotherapeutics (CLDI) Debt Ratio (2022 - 2025)
Calidi Biotherapeutics (CLDI) posted quarterly Debt Ratio of 0.02 for Q4 2025, down 89.04% year-over-year from 0.21 in Q4 2024, and down 20.8% quarter-over-quarter from 0.03 in Q3 2025.
Calidi Biotherapeutics (CLDI) Debt Ratio (2022 - 2025) Analysis & Trends
Calidi Biotherapeutics' Debt Ratio history runs 4 years deep, the most recent figure standing at 0.02 for Q4 2025.
- In Q4 2025, Debt Ratio fell 89.04% year-over-year to 0.02; the TTM figure through Dec 2025 stood at 0.02 (down 89.04% YoY), while the FY2025 annual figure was 0.02, down 89.04% from the prior year.
- Debt Ratio for Q4 2025 stood at 0.02, down from 0.03 in the prior quarter.
- The five-year high for Debt Ratio was 3.31 in Q3 2023, with the low at 0.02 in Q4 2025.
- The 4-year median for Debt Ratio is 0.21 (2024), against an average of 0.55.
- The sharpest annual moves came in 2024 and 2025: Debt Ratio climbed 0.24% in 2024, then plunged 93.26% in 2025.
- Calidi Biotherapeutics' Debt Ratio stood at 0.96 in 2022, then plunged by 78.64% to 0.21 in 2023, then climbed by 0.24% to 0.21 in 2024, then tumbled by 89.04% to 0.02 in 2025.
- Business Quant data shows CLDI's Debt Ratio at 0.02 in Q4 2025, 0.03 in Q3 2025, and 0.09 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 0.05 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.03 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.26 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.47 |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.02 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.09 |
| Mar 31, 2025 | 0.07 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.42 |
| Jun 30, 2024 | 0.42 |
| Mar 31, 2024 | 0.37 |
| Dec 31, 2023 | 0.21 |
| Sep 30, 2023 | 3.31 |
| Dec 31, 2022 | 0.96 |